No abstract available
Keywords:
autoimmune encephalitis; epilepsy.
PubMed Disclaimer
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies.
McGinty RN, Handel A, Moloney T, Ramesh A, Fower A, Torzillo E, Kramer H, Howell S, Waters P, Adcock J, Sen A, Lang B, Irani SR.
McGinty RN, et al.
J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):291-294. doi: 10.1136/jnnp-2020-325011. Epub 2020 Nov 20.
J Neurol Neurosurg Psychiatry. 2021.
PMID: 33219046
Free PMC article.
References
-
-
Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev 2017;97:839–87. 10.1152/physrev.00010.2016
-
DOI
-
PMC
-
PubMed
-
-
Toledano M, Britton JW, McKeon A, et al. . Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology 2014;82:1578–86. 10.1212/WNL.0000000000000383
-
DOI
-
PMC
-
PubMed
-
-
Mc Ginty R, Handel A, Moloney T. Clinical features which predictneuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies. J Neurol Neurosurg Psychiatry 2021;92:291–4.
-
PMC
-
PubMed
-
-
Dubey D, Alqallaf A, Hays R, et al. . Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol 2017;74:397–402. 10.1001/jamaneurol.2016.5429
-
DOI
-
PubMed
-
-
von Rhein B, Wagner J, Widman G, et al. . Suspected antibody negative autoimmune limbic encephalitis: outcome of immunotherapy. Acta Neurol Scand 2017;135:134–41. 10.1111/ane.12575
-
DOI
-
PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous